CEN Biotech, Inc.

Equities

CENBF

CA15130L1040

Market Closed - OTC Markets Other stock markets 07:01:05 16/05/2024 pm IST			5-day change	1st Jan Change
0.0002 ^USD	-93.75%		0.00%	-93.33%

2023	CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer	CI
2022	CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI

CEN Biotech, Inc. Appoints Bahige Chaaban as Chief Executive Officer

April 20, 2021 at 02:34 am IST

On April 19, 2021, the Board of Directors of CEN Biotech, Inc. appointed Mr. Bahige (Bill) Chaaban to serve as Chief Executive Officer of the Company effective April 19, 2021. Mr. Chaaban is currently the Chairman of the Company’s Board and served as Interim CEO since November 13, 2019 until April 19, 2021. Previously, Mr. Chaaban served as the Chief Executive Officer of the Company from the Company’s inception in August 2013 until July 2017.

Latest news about CEN Biotech, Inc.

CEN Biotech, Inc. Announces Resignation of Lawrence Lehoux as a Member of the Board and Chief Technology Officer	30/23/30	CI
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	15/22/15	CI
CEN Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	23/22/23	CI
CEN Biotech, Inc. announced that it has received $0.07 million in funding from 1800 Diagonal Lending, LLC	24/22/24	CI
CEN Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	21/22/21	CI
CEN Biotech, Inc. Announces Changes to Its Board	22/22/22	CI
CEN Biotech, Inc. Announces Management Changes	19/22/19	CI
CEN Biotech, Inc. Announces Executive Changes	19/22/19	CI
CEN Biotech, Inc. Announces Executive Changes	19/22/19	CI
CEN Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	15/22/15	CI
CEN Biotech, Inc. Auditor Raises 'Going Concern' Doubt	14/22/14	CI
CEN Biotech, Inc. Announces Executive Changes	09/21/09	CI
CEN Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	20/21/20	CI
Cen Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	13/21/13	CI
CEN Biotech, Inc. (OTCPK:CENB.F) completed the acquisition of Clear Com Media Inc. from Lawrence Lehoux, Kellie Coulter, Chelsea Lehoux, Joanne Lehoux and Joshua Lehoux.	09/21/09	CI
Cen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	13/21/13	CI
CEN Biotech, Inc. Announces Board Appointments	20/21/20	CI
CEN Biotech, Inc. (OTCPK:CENB.F) entered into a Share Exchange Agreement to acquire Clear Com Media Inc. from Lawrence Lehoux, Kellie Coulter, Chelsea Lehoux, Joanne Lehoux and Joshua Lehoux for $5 million.	20/21/20	CI
CEN Biotech, Inc. Appoints Bahige Chaaban as Chief Executive Officer	20/21/20	CI
Cen Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2020	13/21/13	CI
Cen Biotech, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	06/20/06	CI
Cen Biotech, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	31/20/31	CI
Cen Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	12/20/12	CI
CEN Biotech, Inc. cancelled the acquisition of 70% of the outstanding common stock in the capital of AstralENERGY Solar Manufacturing Corporation, LTD.	19/20/19	CI
Cen Biotech, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	14/20/14	CI

Chart CEN Biotech, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company